These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743 [TBL] [Abstract][Full Text] [Related]
7. Building clinical trials capacity for tuberculosis drugs in high-burden countries. Schluger N; Karunakara U; Lienhardt C; Nyirenda T; Chaisson R PLoS Med; 2007 Nov; 4(11):e302. PubMed ID: 17988170 [TBL] [Abstract][Full Text] [Related]
8. Update on tuberculosis: TB in the early 21st century. Connell DW; Berry M; Cooke G; Kon OM Eur Respir Rev; 2011 Jun; 20(120):71-84. PubMed ID: 21632795 [No Abstract] [Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. [Progress in research of prophylactic therapy in contacts of rifampicin-resistant tuberculosis patients]. Wang Z; Wang WJ; Ding XY; Lu P; Zhu LM; Liu Q; Lu W Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Mar; 44(3):470-476. PubMed ID: 36942344 [TBL] [Abstract][Full Text] [Related]
11. Newer Drugs for Tuberculosis Prevention and Treatment in Children. Marais BJ Indian J Pediatr; 2019 Aug; 86(8):725-731. PubMed ID: 30707347 [TBL] [Abstract][Full Text] [Related]
12. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. Centers for Disease Control and Prevention MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696 [TBL] [Abstract][Full Text] [Related]
13. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. Schito M; Migliori GB; Fletcher HA; McNerney R; Centis R; D'Ambrosio L; Bates M; Kibiki G; Kapata N; Corrah T; Bomanji J; Vilaplana C; Johnson D; Mwaba P; Maeurer M; Zumla A Clin Infect Dis; 2015 Oct; 61Suppl 3(Suppl 3):S102-18. PubMed ID: 26409271 [TBL] [Abstract][Full Text] [Related]
14. Evidence for Implementation: Management of TB in HIV and Pregnancy. Jones AJ; Mathad JS; Dooley KE; Eke AC Curr HIV/AIDS Rep; 2022 Dec; 19(6):455-470. PubMed ID: 36308580 [TBL] [Abstract][Full Text] [Related]
15. Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis. Adler-Shohet FC; Low J; Carson M; Girma H; Singh J Pediatr Infect Dis J; 2014 Jun; 33(6):664-6. PubMed ID: 24445837 [TBL] [Abstract][Full Text] [Related]
16. Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis. Marks SM; Mase SR; Morris SB Clin Infect Dis; 2017 Jun; 64(12):1670-1677. PubMed ID: 28329197 [TBL] [Abstract][Full Text] [Related]
17. Current and future treatments for tuberculosis. Lee A; Xie YL; Barry CE; Chen RY BMJ; 2020 Mar; 368():m216. PubMed ID: 32122882 [TBL] [Abstract][Full Text] [Related]
18. 2011: the year in review. part I: tuberculosis. Chang KC; Nuermberger EL Int J Tuberc Lung Dis; 2012 Jun; 16(6):740-8. PubMed ID: 22613685 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis. van der Laan LE; Garcia-Prats AJ; Schaaf HS; Tikiso T; Wiesner L; de Kock M; Winckler J; Norman J; McIlleron H; Denti P; Hesseling AC Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133558 [TBL] [Abstract][Full Text] [Related]